Literature DB >> 12648693

Effects of hospital volume on life expectancy after selected cancer operations in older adults: a decision analysis.

Emily V A Finlayson1, John D Birkmeyer.   

Abstract

BACKGROUND: In addition to lower operative mortality, patients undergoing selected cancer operations at high volume centers have improved longterm survival. We sought to determine the overall effect of hospital volume on life expectancy after cancer surgery. STUDY
DESIGN: We used a Markov decision analysis model to estimate life expectancy for patients undergoing resection for pancreatic, lung, or colon cancer. Model inputs included probabilities of operative mortality and longterm survival. For input data, we examined operative mortality (in-hospital or within 30 days) stratified by volume in over 400,000 patients undergoing resection for these three cancers using the national Medicare database (1994-1999). Risks of late mortality were abstracted from published studies (MEDLINE, 1966 to present) to model the effect of hospital volume on longterm survival. In analysis, we first calculated life expectancy for patients undergoing surgery at very low, low, medium, high, and very high volume hospitals. We then explored the effects of various regionalization strategies.
RESULTS: Life expectancy increased steadily with hospital volume for all three cancers. Life expectancy after pancreatic cancer resection increased linearly with hospital volume: from 1.9 years at very low volume centers to 3.6 years at very high volume centers. For lung cancer, life expectancy ranged from 5.4 to 6.6 years. Increases in life expectancy for colon cancer were not as dramatic: from 6.8 at very low volume hospitals to 7.4 years at very high volume hospitals. Differences in life expectancy across volume strata were largely attributable to differences in longterm survival, not operative mortality. From a policy perspective, regionalizing surgery for colon cancer would produce the greatest overall life-expectancy gains, but it would require moving most patients.
CONCLUSIONS: Patients aged 65 and older with pancreatic, lung, and colon cancer have substantially greater life expectancy after cancer resection at higher volume hospitals. Further work is needed to understand the mechanisms underlying differences in performance across hospitals in cancer care. Copyright 2003 by the American College of Surgeons

Entities:  

Mesh:

Year:  2003        PMID: 12648693     DOI: 10.1016/S1072-7515(02)01753-2

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  32 in total

1.  The volume-outcome relationship in cancer surgery: a hard sell.

Authors:  Ingemar Ihse
Journal:  Ann Surg       Date:  2003-12       Impact factor: 12.969

Review 2.  Outcomes in oncologic surgery: does volume make a difference?

Authors:  David J Bentrem; Murray F Brennan
Journal:  World J Surg       Date:  2005-10       Impact factor: 3.352

Review 3.  Trials of gene therapy for pancreatic carcinoma.

Authors:  Christopher M Halloran; Paula Ghaneh; Eithne Costello; John P Neoptolemos
Journal:  Curr Gastroenterol Rep       Date:  2005-06

4.  Cost-effectiveness of referrals to high-volume hospitals: an analysis based on a probabilistic Markov model for hip fracture surgeries.

Authors:  Afschin Gandjour; Eva-Julia Weyler
Journal:  Health Care Manag Sci       Date:  2006-11

5.  Hospital volume and surgical outcomes of lung cancer in Japan.

Authors:  Hiroaki Osada; Etsuko Yamakoshi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2007-09

Review 6.  Enhancing surgical performance outcomes through process-driven care: a systematic review.

Authors:  Philip H Pucher; Rajesh Aggarwal; Pritam Singh; Ara Darzi
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

7.  Pancreaticoduodenal resection for malignancy in a low-volume center: long-term outcomes from a developing country.

Authors:  Abu Bakar Hafeez Bhatti; Mohammad Aasim Yusuf; Syed Ather Saeed Kazmi; Aamir Ali Syed
Journal:  World J Surg       Date:  2014-10       Impact factor: 3.352

8.  Ethical debate: the ethics of not performing extended lymphadenectomy in patients with gastrointestinal cancer.

Authors:  Alberto R Ferreres
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

Review 9.  Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.

Authors:  Nico van Zandwijk; Christopher Clarke; Douglas Henderson; A William Musk; Kwun Fong; Anna Nowak; Robert Loneragan; Brian McCaughan; Michael Boyer; Malcolm Feigen; David Currow; Penelope Schofield; Beth Ivimey Nick Pavlakis; Jocelyn McLean; Henry Marshall; Steven Leong; Victoria Keena; Andrew Penman
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

10.  Population-based review of the outcomes following hepatic resection in a Canadian health region.

Authors:  Elijah Dixon; Oliver F Bathe; Andrew McKay; Isabelle You; Scot Dowden; David Sadler; Kelly W Burak; J Gregory McKinnon; Walter Miller; Francis R Sutherland
Journal:  Can J Surg       Date:  2009-02       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.